Founded in 2013 and based in San Diego, California, Arcturus Therapeutics is a clinical-stage mRNA medicines and vaccines company with enabling technologies: (i) LUNAR® lipid-mediated delivery, (ii) STARR™ mRNA,and (iii) mRNA drug substance along with drug product manufacturing expertise. Arcturus’ diverse pipeline includes self-replicating mRNA vaccine programs for SARS-CoV-2 (COVID-19) and Influenza, and other programs to potentially treat Ornithine Transcarbamylase (OTC) Deficiency, Cystic Fibrosis, Cardiovascular Disease along with multiple diverse partnered programs.